BioLineRx Reports First Quarter 2022 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to BioLineRx Reports First Quarter 2022 Financial Results and Provides Corporate Update

BioLineRx (BLRX) Tops Q1 EPS by 13c

May 11, 2022 7:11 AM EDT

BioLineRx (NASDAQ: BLRX) reported Q1 EPS of ($0.02), $0.13 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

... More